Canadian Immunization Guide
Seventh Edition - 2006

Table of Contents

• Message from the Chief Public Health Officer, Public Health Agency of Canada
• Preface
• Preamble
• National Advisory Committee on Immunization - Membership List

Part 1
General Guidelines

• General Considerations
  Table 1. Type and Contents of Vaccines Currently Approved for Use in Canada (May 2006)
  
• The Benefits of Vaccines
  
• National Guidelines for Immunization Practices
  
• Communicating Effectively about Immunization
  
• Principles of Combination Vaccines
  
• Principles of Vaccine Interchangeability
  
• Vaccine Administration Practices
  
• Storage and Handling of Immunizing Agents
  
• Timing of Vaccine Administration
  
• Recent Administration of Human Immune Globulin Products
  
• Immunization Records

Part 2
Vaccine Safety and Adverse Events Following Immunization

• Vaccine Safety
  
• General Contraindications and Precautions
  
• Anaphylaxis: Initial Management in Non-Hospital Settings
  
• Anaphylactic Hypersensitivity to Egg and Egg-Related Antigens

Part 3
Recommended Immunization

• Recommended Immunization Schedules
  
• Immunization of Adults
  
• Immunization of Children and Adults with Inadequate Immunization Records
  
• Immunization in Pregnancy and Breast-Feeding
  
• Immunization of Infants Born Prematurely
  
• Immunization of Patients in Health Care Institutions
  
• Immunization of Immunocompromised Persons
  
• Immunization of Persons with Neurologic Disorders
  
• Immunization of Persons with Bleeding Disorders
  
• Immunization of Travellers
  
• Immunization of Persons New to Canada

Part 4
Active Immunizing Agents

• Bacille Calmette-Guérin (BCG) Vaccine
  
• Cholera Vaccine
  
• Diphtheria Toxoid
  
• Haemophilus Vaccine
  
• Hepatitis A Vaccine
  
• Hepatitis B Vaccine
  
• Hepatitis Vaccines Combined
  
• Influenza Vaccine
  
• Japanese Encephalitis Vaccine
  
• Measles Vaccine
  
• Meningococcal Vaccine
  
• Mumps Vaccine
  
• Pertussis Vaccine
  
• Pneumococcal Vaccine
  
• Poliomyelitis Vaccine
  
• Rabies Vaccine
  
• Rubella Vaccine
  
• Smallpox Vaccine
  
• Tetanus Toxoid
  
• Typhoid Vaccine
  
• Varicella Vaccine
  
• Yellow Fever Vaccine

Part 5
Passive Immunization

• Passive Immunizing Agents
• Immune Globulin (Human)
• Recommended Usage
  • Measles
  • Hepatitis A
  • Rubella
  • Hepatitis C
• Safety of Immunoglobulin Preparations
• Adverse Reactions
• Contraindications and Precautions
• Specific Immune Globulins
  • Botulism antitoxin (equine)
  • Diphtheria antitoxin (equine)
  • Hepatitis B immune globulin (HBIg)
  • Rabies immune globulin (RabIg)
  • Palivizumab (RSVAb)
  • Tetanus immune globulin (TIg)
  • Varicella-zoster immune globulin (VarIg)

Appendix
Abbreviations for Products Available in Canada

Index

Comparison of Effects of Diseases and Vaccines

---

For additional copies, contact:

Publishing and Depository Services Public Works and Government Services Canada, Ottawa, Ontario K1A 0S5

Telephone: 613-941-5995 or 1-800-635-7943
Fax: 613-954-5779 or 1-800-565-7757
E-mail: publications@pwgsc.gc.ca
Government of Canada Publications

All rights reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means, electronic, mechanical, photocopying, recording or otherwise, without prior written permission of the Minister of Public Works and Government Services, Ottawa, Ontario K1A 0S5

© Her Majesty the Queen in Right of Canada, represented by the Minister of Public Works and Government Services Canada, 2006